Vitamin E is the key: a pharmacist has discovered a substance that ‘switches off’ inflammation

Vitamin E is known for its beneficial effect on immune processes. Researchers have now even discovered that it has a dual effect on inflammation-regulating signalling molecules. Photo: Catalin/Adobe Stock.

Alzheimer’s, obesity or atherosclerosis: many lifestyle-related diseases are driven by or accompanied by inflammation. “Treatments usually aim to halt the progression of inflammation. However, for a long-term cure, it must be completely resolved,” explains Andreas Koeberle, a pharmacist at the University of Graz. Normally, the body carries out this work itself. However, if this process does not function properly, chronic inflammation can develop, which can contribute to conditions such as cardiovascular disease or cancer.

As part of an international research project, Koeberle investigated active substances that have the potential both to act as anti-inflammatories and to resolve existing inflammation. The team made a discovery in the form of a type of vitamin E: “This molecule has the dual effect we were looking for on inflammation-regulating signalling molecules. It also protects cells from ferroptosis, a type of cell death that can contribute to the inflammatory response,” explains Koeberle.

The substance identified can be produced in the human body and also bears a strong resemblance to a compound found in the bitter cola plant. This plant has long been used in traditional African medicine to treat inflammatory conditions. “However, it remains to be confirmed whether the two slightly different compounds have the same mechanism of action,” explains the researcher.

Further studies are needed

Vitamin E is known for its positive influence on immune processes. Researchers from Graz, Innsbruck, Angers (France), Jena (Germany) and Naples (Italy) have therefore investigated this substance, as well as 24 of its derivatives, which can also be produced in the human body. “To demonstrate the therapeutic benefit, further experiments are now needed, particularly in models that replicate inflammation-driven tissue damage,” adds Koeberle. The results of the current study have been published in the journal *Acta Pharmaceutica Sinica B*.

Publication:
Permann, S., Brunner, E., Alsabil, K., Werner, M., Waltl, L., Viault, G., D’Avino, D., Perkowski, B., Siller, A., Fritsch, L., Perna, S., Schennach, H., Séraphin, D., Koeberle, S.C., Jordan, P., Roviezzo, F., Richomme, P., Rossi, A., Helesbeux, J.J., Werz, O., Koeberle, A. (2026) Tocotrienol metabolites redirect lipid mediator production in innate immune cells towards inflammation resolution. Acta Pharm Sinica B, https://doi.org/10.1016/j.apsb.2026.06.056

>> Anyone interested in researching active substances can study Pharmaceutical Sciences at the University of Graz.

Gerhild Leljak

Related news

Legal scholar Clarissa Groß on European values at the EU’s external borders

The tense situation in the Spanish exclave of Ceuta has been making headlines for weeks. The exodus of thousands of Moroccans has once again placed migration and border policy at the very top of the EU’s agenda. Clarissa Groß, a research assistant at the Institute for European Law, is examining the reform of the Common European Asylum System (CEAS), the design and practical implementation of the new border procedures, and their compatibility with the right to personal liberty as part of her doctoral thesis. She recently visited the Greek island of Lesbos, which remains a migration hotspot, to assess the situation on the ground.

Graz is a magnet for 750 physicists: international conference on campus

Whether in mobile phones, medical devices or solar power systems: physical phenomena are part of our everyday lives. The vast scope of this discipline will be explored at a major conference taking place at the University of Graz from 20 to 25 September 2026. More than 750 scientists will transform the campus into a European hub for physics.

A fresh start, a calling, holidays: what draws people from other career paths to teaching

They used to develop software; now they teach maths in the classroom. Career changers are expected to help address the shortage of qualified teachers in Austria’s schools. In their doctoral theses at the Institute for Educational Research and Teacher Training at the University of Graz, Melanie Gürentz and Claudia Mair examined how these new teachers perceive their new professional roles.

Talent Talks bridge the gap in career guidance

The Styrian Chamber of Commerce (WKO Steiermark), the Styrian Chamber of Labour (AK Steiermark) and the AMS are joining forces when it comes to training young people and, through the “Talent Talks”, are creating a seamless pathway to career guidance. This takes preparation and follow-up support – just in time for the start of the term and the scheme’s tenth anniversary – to a whole new level. A new survey conducted by the Talent Centre among 2,687 former participants to mark the anniversary shows just how important this development is. Of the young people who received follow-up support from the Talent Report, 74.6 per cent stated that they had a good understanding of their own strengths and talents following the Talent Check. Without follow-up support, the figure was 66.5 per cent – a significant difference of 8.1 percentage points.